000 02266nam  2200373zi 4500
0019.906094
003CaOODSP
00520221104094830
006m     o  d f      
007cr mn|||||||||
008211216e199802##onc     o    f000 0 eng d
020 |z0662633989
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aC21-22/1-1998E-PDF|zC21-22/1-1998
24500|aRenewal of the Canadian biotechnology strategy : |broundtable consultation document / |cprepared by Canadian Biotechnology Strategy Task Force.
264 1|aOttawa ON : |bGovernment of Canada = Gouvernement du Canada, |cFebruary 1998.
300 |a1 online resource (17 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aDigitized edition from print [produced by Innovation, Science and Economic Development Canada].
500 |aIssued also in French under title: Renouvellement de la Stratégie canadienne en matière de biotechnologie : document pour les consultations en table ronde.
500 |aIssued by: Industry Canada.
520 |a"Biotechnology makes significant contributions to our lives. It enhances our health and well-being, creates jobs and economic growth, and supports environmental sustainability. But some of biotechnology's newer techniques (such as cloning), despite their potential benefits, raise certain questions about possible risks to health and the environment, and give rise to social and ethical issues. These questions and issues require careful consideration and discussion"--Introduction, page [1].
530 |aIssued also in printed form.
650 0|aBiotechnology|zCanada.
650 0|aBiotechnology|xGovernment policy|zCanada.
650 0|aBiotechnology|zCanada|xCitizen participation.
7102 |aCanadian Biotechnology Strategy Task Force‏, |eissuing body.
77508|tRenouvellement de la Stratégie canadienne en matière de biotechnologie : |w(CaOODSP)9.906095
7760#|tRenewal of the Canadian Biotechnology Strategy: roundtable consultation document |w(CaOODSP)9.659917
85640|qPDF|s3.36 MB|uhttps://publications.gc.ca/collections/collection_2021/isde-ised/C21-22-1-1998-eng.pdf